Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acharyya, 2012, A CXCL1 paracrine network links cancer chemoresistance and metastasis, Cell, 150, 165, 10.1016/j.cell.2012.04.042
Ahmadzadeh, 2005, TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells, J. Immunol., 174, 5215, 10.4049/jimmunol.174.9.5215
Ahn, 2015, Mitochondria as biosynthetic factories for cancer proliferation, Cancer Metab., 3, 1, 10.1186/s40170-015-0128-2
Ajabnoor, 2012, Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells, Cell Death Dis., 3, 10.1038/cddis.2011.139
Al-Akra, 2018, Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones, J. Biol. Chem., 293, 3562, 10.1074/jbc.M116.772699
Alexander, 2015, Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis, Cancer Biol. Ther., 16, 1802, 10.1080/15384047.2015.1078025
Alexander, 2016, Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment, Oncotarget, 7, 85291, 10.18632/oncotarget.13300
Allavena, 2008, The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages, Crit. Rev. Oncol. Hematol., 66, 1, 10.1016/j.critrevonc.2007.07.004
Almeida, 2019, Bad company: microenvironmentally mediated resistance to targeted therapy in melanoma, Pigment Cell Melanoma Res., 32, 237, 10.1111/pcmr.12736
Amornsupak, 2014, Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells, BMC Cancer, 14, 955, 10.1186/1471-2407-14-955
Andtbacka, 2016, Patterns of clinical response with Talimogene Laherparepvec (T-VEC) in patients with melanoma treated in the OPTiM Phase III clinical trial, Ann. Surg. Oncol., 23, 4169, 10.1245/s10434-016-5286-0
Arumugam, 2009, Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer, Cancer Res., 69, 5820, 10.1158/0008-5472.CAN-08-2819
Assaraf, 1994, Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation, Eur. J. Biochem., 222, 813, 10.1111/j.1432-1033.1994.tb18928.x
Assaraf, 1989, Sequential amplification of dihydrofolate reductase and multidrug resistance genes in Chinese hamster ovary cells selected for stepwise resistance to the lipid-soluble antifolate trimetrexate, J. Biol. Chem., 264, 18326, 10.1016/S0021-9258(18)51467-8
Assaraf, 2019, The multi-factorial nature of clinical multidrug resistance in cancer, Drug Resist. Updat., 46, 10.1016/j.drup.2019.100645
Assaraf, 2006, The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis, Drug Resist. Updat., 9, 227, 10.1016/j.drup.2006.09.001
Babina, 2014, A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44, Breast Cancer Res., 16, R19, 10.1186/bcr3614
Badowska-Kozakiewicz, 2017, Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1alpha, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes, Arch. Med. Sci., 13, 1303, 10.5114/aoms.2016.62723
Bao, 2015, Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells, Mol. Med. Rep., 11, 91, 10.3892/mmr.2014.2671
Bartlett, 2004, The evolution of thalidomide and its IMiD derivatives as anticancer agents, Nat. Rev. Cancer, 4, 314, 10.1038/nrc1323
Belkahla, 2017, Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status, Oncotarget, 9, 1114, 10.18632/oncotarget.23305
Bharti, 2016, Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement, Cancer Lett., 375, 51, 10.1016/j.canlet.2016.02.048
Bhattarai, 2018, Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): a “structure-activity relationship” perspective, Med. Res. Rev., 38, 1404, 10.1002/med.21477
Bierie, 2010, Transforming growth factor beta (TGF-beta) and inflammation in cancer, Cytokine Growth Factor Rev., 21, 49, 10.1016/j.cytogfr.2009.11.008
Blattner, 2018, CCR5(+) myeloid-derived suppressor cells are enriched and activated in melanoma lesions, Cancer Res., 78, 157, 10.1158/0008-5472.CAN-17-0348
Bonuccelli, 2010, The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts, Cell Cycle, 9, 1960, 10.4161/cc.9.10.11601
Borsellino, 1995, Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines, Cancer Res., 55, 4633
Bromberg, 2009, Inflammation and cancer: IL-6 and STAT3 complete the link, Cancer Cell, 15, 79, 10.1016/j.ccr.2009.01.009
Brozovic, 2017, The relationship between platinum drug resistance and epithelial-mesenchymal transition, Arch. Toxicol., 91, 605, 10.1007/s00204-016-1912-7
Bullock, 2013, Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression, Cell Death Dis., 4, e684, 10.1038/cddis.2013.213
Bunt, 2006, Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression, J. Immunol., 176, 284, 10.4049/jimmunol.176.1.284
Bussard, 2016, Tumor-associated stromal cells as key contributors to the tumor microenvironment, Breast Cancer Res., 18, 84, 10.1186/s13058-016-0740-2
Cai, 2015, FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer, Cancer Lett., 367, 129, 10.1016/j.canlet.2015.07.001
Cai, 2018, Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells, Onco. Ther., 12, 291, 10.2147/OTT.S190118
Cammarota, 2016, Mesenchymal stem/stromal cells in stromal evolution and cancer progression, Stem Cells Int., 2016, 10.1155/2016/4824573
Cannarile, 2017, Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy, J. Immunother. Cancer, 5, 53, 10.1186/s40425-017-0257-y
Cassetta, 2019, Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets, Cancer Cell, 35, e510
Chakraborty, 2007, Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells, Urology, 69, 1210, 10.1016/j.urology.2007.02.035
Chang, 2013, Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy, Int. J. Cancer, 132, 1977, 10.1002/ijc.27892
Chang, 2017, EGF induced RET inhibitor eesistance in CCDC6-RET lung cancer cells, Yonsei Med. J., 58, 9, 10.3349/ymj.2017.58.1.9
Chen, 2019, Turning foes to friends: targeting cancer-associated fibroblasts, Nat. Rev. Drug Discov., 18, 99, 10.1038/s41573-018-0004-1
Chen, 2010, Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein, Chin. J. Cancer, 29, 151, 10.5732/cjc.009.10447
Chen, 2012, SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells, PLoS One, 7
Chen, 2014, HIF-1alpha inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein, PLoS One, 9
Chen, 2016, Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers, Cell Oncol, 39, 411, 10.1007/s13402-016-0285-5
Chen, 2018, Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition, Onco. Ther., 11, 3817, 10.2147/OTT.S168317
Chen, 2019, Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment, Cell Death Dis., 10, 508, 10.1038/s41419-019-1748-1
Cheng, 2007, Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel, Cancer Res., 67, 1979, 10.1158/0008-5472.CAN-06-1479
Chittaranjan, 2014, Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer, Clin. Cancer Res., 20, 3159, 10.1158/1078-0432.CCR-13-2060
Chiu, 2015, FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells, Oncotarget, 6, 2349, 10.18632/oncotarget.2957
Chou, 2012, Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1, Neuro Oncol, 14, 1227, 10.1093/neuonc/nos195
Cohen, 2009, FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme, Oncologist, 14, 1131, 10.1634/theoncologist.2009-0121
Colak, 2014, Cancer stem cells--important players in tumor therapy resistance, FEBS J., 281, 4779, 10.1111/febs.13023
Colak, 2017, Targeting TGF-beta signaling in Cancer, Trends Cancer, 3, 56, 10.1016/j.trecan.2016.11.008
Colegio, 2014, Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, 513, 559, 10.1038/nature13490
Comerford, 2002, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene, Cancer Res., 62, 3387
Comerford, 2004, c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia, Cancer Res., 64, 9057, 10.1158/0008-5472.CAN-04-1919
Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007
Coquelle, 1998, A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs, Mol. Cell, 2, 259, 10.1016/S1097-2765(00)80137-9
Coussens, 2013, Neutralizing tumor-promoting chronic inflammation: a magic bullet?, Science, 339, 286, 10.1126/science.1232227
Cui, 2018, Modulating ROS to overcome multidrug resistance in cancer, Drug Resist. Updat., 41, 1, 10.1016/j.drup.2018.11.001
Culig, 2012, Interleukin-6: a multifunctional targetable cytokine in human prostate cancer, Mol. Cell. Endocrinol., 360, 52, 10.1016/j.mce.2011.05.033
da Fonseca, 2016, Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?, Front. Oncol., 6, 158, 10.3389/fonc.2016.00158
Dalton, 2017, Macrophages facilitate resistance to Anti-VEGF therapy by altered VEGFR expression, Clin. Cancer Res., 23, 7034, 10.1158/1078-0432.CCR-17-0647
Dammeijer, 2017, Depletion of tumor-associated macrophages with a CSF-1R kinase inhibitor enhances antitumor immunity and survival induced by DC immunotherapy, Cancer Immunol. Res., 5, 535, 10.1158/2326-6066.CIR-16-0309
Danckwardt, 2011, p38 MAPK controls prothrombin expression by regulated RNA 3’ end processing, Mol. Cell, 41, 298, 10.1016/j.molcel.2010.12.032
Daroqui, 2012, TGF-beta autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression, Oncol. Rep., 28, 567, 10.3892/or.2012.1813
De Craene, 2013, Regulatory networks defining EMT during cancer initiation and progression, Nat. Rev. Cancer, 13, 97, 10.1038/nrc3447
De Palma, 2013, Macrophage regulation of tumor responses to anticancer therapies, Cancer Cell, 23, 277, 10.1016/j.ccr.2013.02.013
DeNardo, 2011, Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy, Cancer Discov., 1, 54, 10.1158/2159-8274.CD-10-0028
Deng, 2016, Twist mediates an aggressive phenotype in human colorectal cancer cells, Int. J. Oncol., 48, 1117, 10.3892/ijo.2016.3342
Deniz, 2019, Treatment sequences for advanced renal cell carcinoma: a health economic assessment, PLoS One, 14, 10.1371/journal.pone.0215761
Di Mitri, 2015, Molecular pathways: targeting tumor-infiltrating myeloid-derived suppressor cells for Cancer therapy, Clin. Cancer Res., 21, 3108, 10.1158/1078-0432.CCR-14-2261
Diesendruck, 2017, Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges, Drug Resist. Updat., 30, 39, 10.1016/j.drup.2017.02.001
Dijkgraaf, 2013, Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment, Cancer Res., 73, 2480, 10.1158/0008-5472.CAN-12-3542
Ding, 2010, Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells, J. Cancer Res. Clin. Oncol., 136, 1697, 10.1007/s00432-010-0828-5
Donadelli, 2011, Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism, Cell Death Dis., 2, 10.1038/cddis.2011.36
Dongre, 2019, New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer, Nature Rev Mol Cell Biol, 20, 69, 10.1038/s41580-018-0080-4
Doublier, 2012, HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast, BMC Cancer, 12, 4, 10.1186/1471-2407-12-4
Du, 2016, Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer, Molecules, 21
Dudas, 2020, Epithelial to mesenchymal transition: a mechanism that fuels cancer radio/chemoresistance, Cells, 9, 428, 10.3390/cells9020428
Dumitru, 2012, Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology, Cancer Immunol. Immunother., 61, 1155, 10.1007/s00262-012-1294-5
Ebos, 2009, Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy, Clin. Cancer Res., 15, 5020, 10.1158/1078-0432.CCR-09-0095
Efferth, 2005, Pharmacogenetics for individualized cancer chemotherapy, Pharmacol. Ther., 107, 155, 10.1016/j.pharmthera.2005.02.005
Efferth, 2017, Integration of phytochemicals and phytotherapy into cancer precision medicine, Oncotarget, 8, 50284, 10.18632/oncotarget.17466
El Alaoui-Lasmaili, 2018, Antiangiogenic therapy: markers of response, “normalization” and resistance, Critical Rev Oncolog Hematol, 128, 118, 10.1016/j.critrevonc.2018.06.001
Eriksson, 2016, Gemcitabine reduces MDSCs, tregs and TGFbeta-1 while restoring the teff/treg ratio in patients with pancreatic cancer, J. Transl. Med., 14, 282, 10.1186/s12967-016-1037-z
Erin, 2015, Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response, Oncogene, 34, 3860, 10.1038/onc.2014.317
Erin, 2018, Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer, Breast Cancer Res. Treat., 170, 235, 10.1007/s10549-018-4752-8
Erin, 2018, CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma, Oncotarget, 9, 19147, 10.18632/oncotarget.24931
Erin, 2020, CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1, Cancer Immunol Immunother CII, 69, 103, 10.1007/s00262-019-02444-3
Fan, 2014, Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma, Cancer Lett., 352, 160, 10.1016/j.canlet.2014.05.008
Farcas, 2019, SIRT1 in the development and treatment of hepatocellular carcinoma, Front. Nutr., 6, 148, 10.3389/fnut.2019.00148
Fendt, 2013, Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism, Cancer Res., 73, 4429, 10.1158/0008-5472.CAN-13-0080
Fiori, 2019, Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance, Mol. Cancer, 18, 70, 10.1186/s12943-019-0994-2
Fischer, 2007, Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels, Cell, 131, 463, 10.1016/j.cell.2007.08.038
Fradette, 2007, Animal models of acute moderate hypoxia are associated with a down-regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and up-regulation of CYP3A6 and P-glycoprotein in liver, Drug Metab. Dispos., 35, 765, 10.1124/dmd.106.013508
Friedman, 2009, Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma, J. Clin. Oncol., 27, 4733, 10.1200/JCO.2008.19.8721
Fujita, 2011, COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells, Cancer Res., 71, 2664, 10.1158/0008-5472.CAN-10-3055
Gabrilovich, 2007, The terminology issue for myeloid-derived suppressor cells, Cancer Res., 67
Gabrilovich, 2012, Coordinated regulation of myeloid cells by tumours, Nat. Rev. Immunol., 12, 253, 10.1038/nri3175
Gacche, 2018, Redundant angiogenic signaling and tumor drug resistance, Drug Resist. Updat., 36, 47, 10.1016/j.drup.2018.01.002
Ganesh, 2018, Peripherally restricted, highly potent, selective, aqueous-soluble EP2 antagonist with anti-inflammatory properties, Mol. Pharm., 15, 5809, 10.1021/acs.molpharmaceut.8b00764
Gao, 2015, Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α, Exp. Cell Res., 332, 236, 10.1016/j.yexcr.2014.11.021
Gao, 2020, CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma, Pharmacol. Res., 157, 10.1016/j.phrs.2020.104800
Gaude, 2016, Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival, Nat. Commun., 7, 13041, 10.1038/ncomms13041
Genovese, 2017, Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins, Drug Resist. Updat., 32, 23, 10.1016/j.drup.2017.10.003
George, 2019, Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer, Urol. Oncol., 79, 1752
Ghandadi, 2016, Interleukin-6: a critical cytokine in Cancer multidrug resistance, Curr. Pharm. Des., 22, 518, 10.2174/1381612822666151124234417
Ginhoux, 2016, New insights into the multidimensional concept of macrophage ontogeny, activation and function, Nat. Immunol., 17, 34, 10.1038/ni.3324
Gonen, 2012, Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance, Drug Resist. Updat., 15, 183, 10.1016/j.drup.2012.07.002
Gong, 2018, Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway, J. Transl. Med., 16, 164, 10.1186/s12967-018-1543-2
Gonzalez, 2014, Signaling mechanisms of the epithelial-mesenchymal transition, Sci. Signal., 7, 10.1126/scisignal.2005189
Goossens, 2017, EMT transcription factors in cancer development re-evaluated: beyond EMT and MET, Biochim. Biophys. Acta Rev. Cancer, 1868, 584, 10.1016/j.bbcan.2017.06.006
Gottesman, 2002, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer, 2, 48, 10.1038/nrc706
Graham, 2008, Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells, Cancer Res., 68, 2479, 10.1158/0008-5472.CAN-07-2559
Greijer, 2005, Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells, Cell Oncol, 27, 43
Grisanti, 2019, Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature, J. Neurosurg. Sci., 63, 458, 10.23736/S0390-5616.16.03874-1
Gritsko, 2006, Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells, Clin. Cancer Res., 12, 11, 10.1158/1078-0432.CCR-04-1752
Grivennikov, 2008, Autocrine IL-6 signaling: a key event in tumorigenesis?, Cancer Cell, 13, 7, 10.1016/j.ccr.2007.12.020
Grotegut, 2006, Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail, EMBO J., 25, 3534, 10.1038/sj.emboj.7601213
Gugnoni, 2016, Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer, Cell Death Dis., 7, e2520, 10.1038/cddis.2016.415
Hagemann, 2008, Re-educating" tumor-associated macrophages by targeting NF-kappaB, J. Exp. Med., 205, 1261, 10.1084/jem.20080108
Haibe, 2020, Resistance mechanisms to anti-angiogenic therapies in cancer, Front. Oncol., 10, 221, 10.3389/fonc.2020.00221
Halsall, 2016, Histone deacetylase inhibitors for cancer therapy: an evolutionarily ancient resistance response may explain their limited success, Bioessays, 38, 1102, 10.1002/bies.201600070
Ham, 2018, Three-dimensional tumor model mimics stromal - breast cancer cells signaling, Oncotarget, 9, 249, 10.18632/oncotarget.22922
Han, 2007, Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation, Biochem. Biophys. Res. Commun., 357, 567, 10.1016/j.bbrc.2007.04.012
Harney, 2009, Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate, Proc Natl Acad Sci U S A, 106, 13667, 10.1073/pnas.0906423106
Harrison, 2017, Osteogenic sarcoma: systemic chemotherapy options for localized disease, Curr Treatm Options Oncol, 18, 24, 10.1007/s11864-017-0464-2
Hart, 2014, CX3CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancer, Immunol. Cell Biol., 92, 499, 10.1038/icb.2014.13
Hartmann, 2005, CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells, Oncogene, 24, 4462, 10.1038/sj.onc.1208621
Haslehurst, 2012, EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer, BMC Cancer, 12, 91, 10.1186/1471-2407-12-91
Hawila, 2017, CCR5 directs the mobilization of CD11b+Gr1+Ly6C(low) polymorphonuclear myeloid cells from the bone marrow to the blood to support tumor development, Cell Rep., 21, 2212, 10.1016/j.celrep.2017.10.104
He, 2019, Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin, Mol. Oncol., 13, 403, 10.1002/1878-0261.12419
Heo, 2013, Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer, Nat. Med., 19, 329, 10.1038/nm.3089
Herbst, 2014, Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients, Nature, 515, 563, 10.1038/nature14011
Heusinkveld, 2011, M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells, J. Immunol., 187, 1157, 10.4049/jimmunol.1100889
Hirsch, 2009, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, Cancer Res., 69, 7507, 10.1158/0008-5472.CAN-09-2994
Hou, 2016, Oncolytic virus-mediated targeting of PGE2 in the tumor alters the immune status and sensitizes established and resistant tumors to immunotherapy, Cancer Cell, 30, 108, 10.1016/j.ccell.2016.05.012
Hou, 2017, The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells, Cell Death Dis., 8, 10.1038/cddis.2017.53
Howe, 2003, Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation, Cancer Res., 63, 1906
Hsieh, 2018, Aspirin disrupts the crosstalk of angiogenic and inflammatory cytokines between 4T1 breast cancer cells and macrophages, Mediators Inflamm., 2018, 10.1155/2018/6380643
Hsu, 2015, Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROalpha and S100A8/A9, Oncol. Rep., 34, 2889, 10.3892/or.2015.4307
Hsu, 2019, CXCL17-derived CD11b(+)Gr-1(+) myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB, Breast Cancer Res., 21, 23, 10.1186/s13058-019-1114-3
Hu, 2018, Effect of TGF-beta1 on blood CD4+CD25(high) regulatory T cell proliferation and Foxp3 expression during non-small cell lung cancer blood metastasis, Exp. Ther. Med., 16, 1403
Huang, 2007, CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers, Cancer Lett., 252, 86, 10.1016/j.canlet.2006.12.012
Huang, 2012, MED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signaling, Cell, 151, 937, 10.1016/j.cell.2012.10.035
Huang, 2019, Azoreductase-responsive metal-organic framework-based nanodrug for enhanced cancer therapy via breaking hypoxia-induced chemoresistance, ACS Appl. Mater. Interfaces, 11, 25740, 10.1021/acsami.9b08115
Huber, 2004, Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells, J. Immunol., 173, 6526, 10.4049/jimmunol.173.11.6526
Hugo, 2016, Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma, Cell, 165, 35, 10.1016/j.cell.2016.02.065
Huijts, 2019, The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial, Cancer Immunol. Immunother., 68, 503, 10.1007/s00262-018-2288-8
Iovine, 2016, L-Carnosine Dipeptide Overcomes Acquired Resistance to 5-fluorouracil in HT29 Human Colon Cancer Cells via Downregulation of HIF1-alpha and Induction of Apoptosis, Biochimie, 127, 196, 10.1016/j.biochi.2016.05.010
Ireland, 2018, Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer, Oncogene, 37, 2022, 10.1038/s41388-017-0115-x
Izumi, 2019, TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer, Cell Death Dis., 10, 267, 10.1038/s41419-019-1493-5
Jögi, 2014, Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior, Exp. Cell Res., 295, 469, 10.1016/j.yexcr.2004.01.013
Jaiswal, 2010, Macrophages as mediators of tumor immunosurveillance, Trends Immunol., 31, 212, 10.1016/j.it.2010.04.001
Javam, 2014, Effect of oxygen on multidrug resistance in term human placenta, Placenta, 35, 324, 10.1016/j.placenta.2014.02.010
Ji, 2010, Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319, J. Exp. Clin. Cancer Res., 29, 158, 10.1186/1756-9966-29-158
Jiang, 2015, Metabolic reprogramming during TGFbeta1-induced epithelial-to-mesenchymal transition, Oncogene, 34, 3908, 10.1038/onc.2014.321
Jin, 2011, Regulation of hypoxia inducible factor-1α expression by the alteration of redox status in HepG2 cells, J. Exp. Clin. Cancer Res., 30, 61, 10.1186/1756-9966-30-61
Jinushi, 2011, Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells, Proc Natl Acad Sci U S A, 108, 12425, 10.1073/pnas.1106645108
Johnson, 2015, Acquired BRAF inhibitor resistance: a multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms, Eur. J. Cancer, 51, 2792, 10.1016/j.ejca.2015.08.022
Jung, 2013, Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis, Nat. Commun., 4, 1795, 10.1038/ncomms2766
Kadel, 2019, Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy, Cell Biol. Toxicol., 35, 407, 10.1007/s10565-019-09461-z
Kadioglu, 2016, Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance, Sci. Rep., 6, 36754, 10.1038/srep36754
Kajita, 2004, Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress, Mol. Cell. Biol., 24, 7559, 10.1128/MCB.24.17.7559-7566.2004
Kajiyama, 2007, Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells, Int. J. Oncol., 31, 277
Kale, 2020, HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators, Naunyn Schmiedebergs Arch Pharmacol., 393, 253, 10.1007/s00210-019-01725-z
Kalinski, 2012, Regulation of immune responses by prostaglandin E2, J. Immunol., 188, 21, 10.4049/jimmunol.1101029
Kalra, 1993, The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro, Int. J. Cancer, 54, 650, 10.1002/ijc.2910540421
Kang, 2017, Down-regulation of TGF-beta expression sensitizes the resistance of hepatocellular carcinoma cells to sorafenib, Yonsei Med. J., 58, 899, 10.3349/ymj.2017.58.5.899
Kang, 2019, Role of metabolic reprogramming in epithelial(-)mesenchymal transition (EMT), Int. J. Mol. Sci., 20
Karagas, 2001, Non-melanoma skin cancers and glucocorticoid therapy, Br. J. Cancer, 85, 683, 10.1054/bjoc.2001.1931
Kawano, 2015, The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer, Sci. Rep., 5, 18217, 10.1038/srep18217
Ketteler, 2018, Caveolin-1, cancer and therapy resistance, Int. J. Cancer, 143, 2092, 10.1002/ijc.31369
Kim, 2017, Targeting tumor adaption to chronic hypoxia: implications for drug resistance, and how it can be overcome, Int. J. Mol. Sci., 18, 1854, 10.3390/ijms18091854
Kim, 2007, Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and Snail, Mol. Cell. Biol., 27, 3165, 10.1128/MCB.01315-06
Kim, 2011, Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation, Br. J. Pharmacol., 162, 1096, 10.1111/j.1476-5381.2010.01101.x
Kim, 2017, Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress, Nat. Commun., 8, 14374, 10.1038/ncomms14374
Kinuya, 2003, Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function, Eur. J. Nucl. Med. Mol. Imaging, 30, 1529, 10.1007/s00259-003-1268-0
Knight, 2012, SIRT1, metabolism and cancer, Curr. Opin. Oncol., 24, 68, 10.1097/CCO.0b013e32834d813b
Knight, 2013, Host immunity contributes to the anti-melanoma activity of BRAF inhibitors, J. Clin. Invest., 123, 1371, 10.1172/JCI66236
Koch, 2003, Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro, Br. J. Cancer, 89, 2133, 10.1038/sj.bjc.6601375
Koleske, 1995, Reduction of caveolin and caveolae in oncogenically transformed cells, Proc Natl Acad Sci U S A, 92, 1381, 10.1073/pnas.92.5.1381
Kon, 2019, Immune checkpoint inhibitor combinations: current efforts and important aspects for success, Drug Resist. Updat., 45, 13, 10.1016/j.drup.2019.07.004
Kowanetz, 2010, Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes, Proc Natl Acad Sci U S A, 107, 21248, 10.1073/pnas.1015855107
Krchniakova, 2020, Repurposing tyrosine kinase inhibitors to overcome multidrug resistance in cancer: a focus on transporters and lysosomal sequestration, Int. J. Mol. Sci., 21
Krishnamurthy, 2004, The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme, J. Biol. Chem., 279, 24218, 10.1074/jbc.M313599200
Kumar, 2016, The nature of myeloid-derived suppressor cells in the tumor microenvironment, Trends Immunol., 37, 208, 10.1016/j.it.2016.01.004
Kumari, 2016, Role of interleukin-6 in cancer progression and therapeutic resistance, Tumour Biol., 37, 11553, 10.1007/s13277-016-5098-7
Kurrey, 2009, Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells, Stem Cells, 27, 2059, 10.1002/stem.154
Lamaze, 2015, Caveolae and cancer: a new mechanical perspective, Biomed. J., 38, 367, 10.4103/2319-4170.164229
Lambies, 2019, TGFbeta-activated USP27X deubiquitinase regulates cell migration and chemoresistance via stabilization of Snail1, Cancer Res., 79, 33, 10.1158/0008-5472.CAN-18-0753
Larouche, 2019, Management of small bowel neuroendocrine tumors, Cancers, 11, 828, 10.3390/cancers11091395
Lazarova, 2017, ZEB1 mediates drug resistance and EMT in p300-deficient CRC, J. Cancer, 8, 1453, 10.7150/jca.18762
LeBleu, 2014, PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis, Nat. Cell Biol., 16, 992, 10.1038/ncb3039
Lee, 2010, Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells, Oncogene, 29, 4576, 10.1038/onc.2010.208
Lee, 2012, Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism, Cancer Res., 72, 3607, 10.1158/0008-5472.CAN-12-0006
Lee, 2014, SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma, Br. J. Cancer, 111, 2122, 10.1038/bjc.2014.528
Leis, 2012, Sox2 expression in breast tumours and activation in breast cancer stem cells, Oncogene, 31, 1354, 10.1038/onc.2011.338
Leonetti, 2019, MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions, Drug Resist. Updat., 42, 1, 10.1016/j.drup.2018.11.002
Leonetti, 2019, Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer, Drug Resist. Updat., 46, 10.1016/j.drup.2019.100644
Leong, 2007, Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin, J. Exp. Med., 204, 2935, 10.1084/jem.20071082
Levi, 2004, Bidirectional relation between inflammation and coagulation, Circulation, 109, 2698, 10.1161/01.CIR.0000131660.51520.9A
Li, 2015, Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation, Pharmacol. Ther., 150, 33, 10.1016/j.pharmthera.2015.01.004
Li, 2005, Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation, Oncogene, 25, 609, 10.1038/sj.onc.1209077
Li, 2006, Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate, Biochem. Biophys. Res. Commun., 342, 1341, 10.1016/j.bbrc.2006.02.094
Li, 2009, Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells, Clin. Cancer Res., 15, 2657, 10.1158/1078-0432.CCR-08-2372
Li, 2011, Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells, Asian Pac. J. Cancer Prev., 12, 2575
Li, 2013, Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux, Toxicol. Lett., 220, 267, 10.1016/j.toxlet.2013.04.021
Li, 2016, mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance, Oncol. Rep., 35, 3523, 10.3892/or.2016.4714
Li, 2016, Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies, Drug Resist. Updat., 27, 14, 10.1016/j.drup.2016.05.001
Li, 2016, G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers, Protein Cell, 7, 130, 10.1007/s13238-015-0237-2
Li, 2016, CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma, Hepatol. Int., 10, 488, 10.1007/s12072-015-9683-4
Li, 2017, Autophagy and multidrug resistance in cancer, Chin. J. Cancer, 36, 52, 10.1186/s40880-017-0219-2
Li, 2018, Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT, Int. J. Oncol., 53, 1763
Li, 2018, Participation of CCL1 in Snail-positive fibroblasts in colorectal cancer contribute to 5-fluorouracil/paclitaxel chemoresistance, Cancer Res. Treat., 50, 894, 10.4143/crt.2017.356
Li, 2019, Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion, Cancer Res., 79, 3903, 10.1158/0008-5472.CAN-18-3604
Li, 2019, Co-delivery of metformin enhances the antimultidrug resistant tumor effect of doxorubicin by improving hypoxic tumor microenvironment, Mol. Pharm., 16, 2966, 10.1021/acs.molpharmaceut.9b00199
Li, 2020, Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer, Cancer Sci., 111, 47, 10.1111/cas.14230
Liang, 2016, Inhibition of autophagy sensitizes MDR-phenotype ovarian cancer SKVCR cells to chemotherapy, Biomed. Pharmacother., 82, 98, 10.1016/j.biopha.2016.04.054
Liang, 1996, Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines, J. Neurooncol., 29, 149, 10.1007/BF00182138
Lin, 2019, Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications, J. Hematol. Oncol., 12, 76, 10.1186/s13045-019-0760-3
Ling, 2014, Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells, Mol. Med. Rep., 10, 2891, 10.3892/mmr.2014.2614
Linn, 1995, Prognostic relevance of P-glycoprotein expression in breast cancer, Ann. Oncol., 6, 679, 10.1093/oxfordjournals.annonc.a059284
Liongue, 2009, Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more, Int. J. Biochem. Cell Biol., 41, 2372, 10.1016/j.biocel.2009.08.011
Liu, 2008, Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer, Cancer Sci., 99, 121, 10.1111/j.1349-7006.2007.00643.x
Liu, 2012, Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth, Mol. Pharm., 9, 2863, 10.1021/mp300193f
Liu, 2016, Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma, Cancer Metabol, 4, 19, 10.1186/s40170-016-0160-x
Liu, 2017, Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-beta1/STAT3 axis-regulated EMT, Cell Death Dis., 8, e3007, 10.1038/cddis.2017.417
Liu, 2017, Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer, Oncotarget, 8, 39559, 10.18632/oncotarget.17136
Liu, 2017, Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters, Oncotarget, 8, 52901, 10.18632/oncotarget.17548
Liu, 2017, A novel individual-cell-based mathematical model based on multicellular tumour spheroids for evaluating doxorubicin-related delivery in avascular regions, Br. J. Pharmacol., 174, 2862, 10.1111/bph.13909
Liu, 2019, Snail-overexpression induces epithelial-mesenchymal transition and metabolic reprogramming in human pancreatic ductal adenocarcinoma and non-tumorigenic ductal cells, J. Clin. Med., 8, 822, 10.3390/jcm8060822
Liu, 2019, Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy, J. Hematol. Oncol., 12, 86, 10.1186/s13045-019-0770-1
Livney, 2013, Rationally designed nanovehicles to overcome cancer chemoresistance, Adv. Drug Deliv. Rev., 65, 1716, 10.1016/j.addr.2013.08.006
Lo, 2007, Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression, Cancer Res., 67, 9066, 10.1158/0008-5472.CAN-07-0575
Lo, 2009, Gene expression profiling of adenosine triphosphate-binding cassette transporters in response to K-ras activation and hypoxia in human pancreatic cancer cell cultures, Pancreas, 38, 85, 10.1097/MPA.0b013e318184aa8a
Long, 2014, Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma, N. Engl. J. Med., 371, 1877, 10.1056/NEJMoa1406037
Lopes-Rodrigues, 2017, Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles, Sci. Rep., 7, 44541, 10.1038/srep44541
Lotti, 2013, Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A, J. Exp. Med., 210, 2851, 10.1084/jem.20131195
Lotz, 2007, Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells, Oncol. Rep., 17, 239
Lu, 2016, Expression of HIF-1alpha and P-gp in non-small cell lung cancer and the relationship with HPV infection, Oncol. Lett., 12, 1455, 10.3892/ol.2016.4751
Lu-Emerson, 2015, Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma, J. Clin. Oncol., 33, 1197, 10.1200/JCO.2014.55.9575
Luk, 1990, Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines, J. Natl. Cancer Inst., 82, 684, 10.1093/jnci/82.8.684
Luo, 2017, Emerging roles of lipid metabolism in cancer metastasis, Mol. Cancer, 16, 76, 10.1186/s12943-017-0646-3
Luo, 2018, Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose, Theranostics, 8, 3584, 10.7150/thno.25409
Lv, 2015, Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer, Onco. Ther., 8, 1941, 10.2147/OTT.S82835
Ma, 2018, Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer, Cancer Cell Int., 18, 104, 10.1186/s12935-018-0599-7
Mallini, 2014, Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance, Cancer Treat. Rev., 40, 341, 10.1016/j.ctrv.2013.09.008
Mantovani, 2004, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol., 25, 677, 10.1016/j.it.2004.09.015
Marie, 2005, TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells, J. Exp. Med., 201, 1061, 10.1084/jem.20042276
Markovic, 2017, Structural features of subtype-selective EP receptor modulators, Drug Discov. Today, 22, 57, 10.1016/j.drudis.2016.08.003
Martinez-Outschoorn, 2014, Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth, Sem Cancer Biol, 25, 47, 10.1016/j.semcancer.2014.01.005
Mazzieri, 2011, Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells, Cancer Cell, 19, 512, 10.1016/j.ccr.2011.02.005
Meidhof, 2015, ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat, EMBO Mol. Med., 7, 831, 10.15252/emmm.201404396
Melero, 2014, T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy, Cancer Discov., 4, 522, 10.1158/2159-8290.CD-13-0985
Mercier, 2008, Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy, Cancer Biol. Ther., 7, 1212, 10.4161/cbt.7.8.6220
Meschini, 2008, The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells, Autophagy, 4, 1020, 10.4161/auto.6952
Meyer, 2011, Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model, Proc Natl Acad Sci U S A, 108, 17111, 10.1073/pnas.1108121108
Middleton, 2013, A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO), Eur. J. Cancer, 49, 3507, 10.1016/j.ejca.2013.06.017
Milman, 2019, Exosomes and their role in tumorigenesis and anticancer drug resistance, Drug Resist. Updat., 45, 1, 10.1016/j.drup.2019.07.003
Mishra, 2008, Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells, Cancer Res., 68, 4331, 10.1158/0008-5472.CAN-08-0943
Mitchem, 2013, Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses, Cancer Res., 73, 1128, 10.1158/0008-5472.CAN-12-2731
Miyake, 2016, CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer, Neoplasia, 18, 636, 10.1016/j.neo.2016.08.002
Moro, 2009, Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2, Cell Death Differ., 16, 571, 10.1038/cdd.2008.178
Morris, 2014, G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration, Br. J. Cancer, 110, 1211, 10.1038/bjc.2013.822
Moustakas, 2012, Induction of epithelial-mesenchymal transition by transforming growth factor beta, Semin. Cancer Biol., 22, 446, 10.1016/j.semcancer.2012.04.002
Murdoch, 2008, The role of myeloid cells in the promotion of tumour angiogenesis, Nat. Rev. Cancer, 8, 618, 10.1038/nrc2444
Muz, 2017, Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance, Leuk. Lymphoma, 58, 2916, 10.1080/10428194.2017.1319052
Naser Al Deen, 2019, Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability, Adv. Exp. Biol., 1152, 335, 10.1007/978-3-030-20301-6_18
Natori, 2002, G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells, Biochem. Biophys. Res. Commun., 297, 1058, 10.1016/S0006-291X(02)02335-5
Nierodzik, 2006, Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype, Cancer Cell, 10, 355, 10.1016/j.ccr.2006.10.002
Niewerth, 2015, Molecular basis of resistance to proteasome inhibitors in hematological malignancies, Drug Resist. Updat., 18, 18, 10.1016/j.drup.2014.12.001
Nikolova, 2017, Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling, Biochim. Biophys. Acta Rev. Cancer, 1868, 29, 10.1016/j.bbcan.2017.01.004
Nizam, 2020, NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences, Cancer Immunol. Immunother., 10.1007/s00262-020-02574-z
Obermajer, 2011, Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells, Blood, 118, 5498, 10.1182/blood-2011-07-365825
Omran, 2017, Physical and biological characteristics of multi drug resistance (MDR): an integral approach considering pH and drug resistance in cancer, Semin. Cancer Biol., 43, 42, 10.1016/j.semcancer.2017.01.002
Oshimori, 2015, TGF-beta promotes heterogeneity and drug resistance in squamous cell carcinoma, Cell, 160, 963, 10.1016/j.cell.2015.01.043
Ostrand-Rosenberg, 2018, Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment, J. Immunol., 200, 422, 10.4049/jimmunol.1701019
Paldino, 2014, Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?, Biomed Res. Int., 2014, 10.1155/2014/859871
Panka, 2013, Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells, Mol. Cancer, 12, 17, 10.1186/1476-4598-12-17
Park, 2019, Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer, Cancer Sci., 110, 2834, 10.1111/cas.14124
Parker, 2015, Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment, Adv. Cancer Res., 128, 95, 10.1016/bs.acr.2015.04.002
Pavlides, 2009, The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma, Cell Cycle, 8, 3984, 10.4161/cc.8.23.10238
Peinado, 2003, Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions, J. Biol. Chem., 278, 21113, 10.1074/jbc.M211304200
Peng, 2016, Loss of PTEN promotes resistance to T cell-mediated immunotherapy, Cancer Discov., 6, 202, 10.1158/2159-8290.CD-15-0283
Peranzoni, 2018, Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment, Proc Natl Acad Sci U S A, 115, E4041, 10.1073/pnas.1720948115
Pinzón-Daza, 2017, Oxidative stress promotes doxorubicin-induced Pgp and BCRP expression in colon cancer cells under hypoxic conditions, J. Cell. Biochem., 118, 1868, 10.1002/jcb.25890
Polanczyk, 2019, Blockade of TGF-beta signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4(+)CD25(+)Foxp3(+) and CD4(+)CD25(-)Foxp3(+) T cells, J. Transl. Med., 17, 219, 10.1186/s12967-019-1967-3
Porporato, 2016, Metabolic changes associated with tumor metastasis, part 2: mitochondria, lipid and amino acid metabolism, Cell. Mol. Life Sci., 73, 1349, 10.1007/s00018-015-2100-2
Prieto-Vila, 2019, Single-cell analysis reveals a preexisting drug-resistant subpopulation in the luminal breast cancer subtype, Cancer Res., 79, 4412, 10.1158/0008-5472.CAN-19-0122
Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014
Qian, 2014, Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells, Cancer Lett., 351, 242, 10.1016/j.canlet.2014.06.008
Qiao, 2018, IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma, Oncogene, 37, 873, 10.1038/onc.2017.387
Qin, 2015, Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma, Toxicol. Appl. Pharmacol., 286, 112, 10.1016/j.taap.2015.03.021
Qu, 2014, Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells, Mol. Cell. Biochem., 386, 63, 10.1007/s11010-013-1845-x
Raz, 2014, Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest, Cell Death Dis., 5, e1067, 10.1038/cddis.2014.39
Ribatti, 2020, Epithelial-mesenchymal transition in cancer: a historical overview, Transl. Oncol., 13, 10.1016/j.tranon.2020.100773
Riganti, 2009, Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells, Toxicol. Appl. Pharmacol., 240, 385, 10.1016/j.taap.2009.07.026
Robey, 2007, ABCG2: determining its relevance in clinical drug resistance, Cancer Metastasis Rev., 26, 39, 10.1007/s10555-007-9042-6
Rodriguez, 2005, Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma, J. Exp. Med., 202, 931, 10.1084/jem.20050715
Rolny, 2011, HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF, Cancer Cell, 19, 31, 10.1016/j.ccr.2010.11.009
Roncuzzi, 2014, Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells, Oncol. Rep., 32, 389, 10.3892/or.2014.3181
Rong, 2013, Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs), PLoS One, 8, 10.1371/journal.pone.0070960
Ruffell, 2012, Differential macrophage programming in the tumor microenvironment, Trends Immunol., 33, 119, 10.1016/j.it.2011.12.001
Rycaj, 2014, Cancer stem cells and radioresistance, Int. J. Radiat. Biol., 90, 615, 10.3109/09553002.2014.892227
Sade-Feldman, 2013, Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation, Immunity, 38, 541, 10.1016/j.immuni.2013.02.007
Saha, 2017, Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade, Cancer Cell, 32, e255
Sakamaki, 2014, Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas, Leukemia, 28, 329, 10.1038/leu.2013.177
Sakata, 1991, Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance, Br. J. Cancer, 64, 809, 10.1038/bjc.1991.405
Salem, 2018, Targeting hypoxia to improve non-small cell lung cancer outcome, J. Natl. Cancer Inst., 110, 10.1093/jnci/djx160
Sanchez-Martinez, 2015, A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy, Oncotarget, 6, 38719, 10.18632/oncotarget.5340
Sarode, 2020, Macrophage and tumor cell cross-talk is fundamental for lung tumor progression: we need to talk, Front. Oncol., 10, 324, 10.3389/fonc.2020.00324
Sasabe, 2007, The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells, Int. J. Cancer, 120, 268, 10.1002/ijc.22294
Sasidharan Nair, 2020, Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer, Clin Epigenet, 12, 13, 10.1186/s13148-020-0808-9
Savagner, 1997, The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition, J. Cell Biol., 137, 1403, 10.1083/jcb.137.6.1403
Savarese, 2001, Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas, Cancer Lett., 162, 105, 10.1016/S0304-3835(00)00623-6
Saxena, 2011, Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters, Cell Death Dis., 2, e179, 10.1038/cddis.2011.61
Schlecker, 2012, Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth, J. Immunol., 189, 5602, 10.4049/jimmunol.1201018
Schmid, 2019, Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor-positive metastatic breast cancer: the MANTA Phase 2 randomized clinical trial, JAMA Oncol., 29, 1556, 10.1001/jamaoncol.2019.2526
Schultze, 2016, Reprogramming of macrophages--new opportunities for therapeutic targeting, Curr. Opin. Pharmacol., 26, 10, 10.1016/j.coph.2015.09.007
Seip, 2016, Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors, Oncotarget, 7, 19997, 10.18632/oncotarget.7671
Sevko, 2013, Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model, J. Immunol., 190, 2464, 10.4049/jimmunol.1202781
Shaked, 2019, The pro-tumorigenic host response to cancer therapies, Nat. Rev. Cancer, 19, 667, 10.1038/s41568-019-0209-6
Shapira, 2011, Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance, Drug Resist. Updat., 14, 150, 10.1016/j.drup.2011.01.003
Sharma, 1991, A phenotype conferring selective resistance to lipophilic antifolates in Chinese hamster ovary cells, Cancer Res., 51, 2949
Shen, 2017, MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer, PLoS One, 12
Shen, 2017, Hypoxia induces multidrug resistance via enhancement of epidermal growth factor-like domain 7 expression in non-small lung cancer cells, Chemotherapy, 62, 172, 10.1159/000456066
Shojaei, 2007, Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells, Nat. Biotechnol., 25, 911, 10.1038/nbt1323
Shojaei, 2007, Bv8 regulates myeloid-cell-dependent tumour angiogenesis, Nature, 450, 825, 10.1038/nature06348
Shojaei, 2009, G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models, Proc Natl Acad Sci U S A, 106, 6742, 10.1073/pnas.0902280106
Si, 2019, The role and mechanisms of action of microRNAs in cancer drug resistance, Clin Epigenet, 11, 25, 10.1186/s13148-018-0587-8
Siebzehnrubl, 2013, The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance, EMBO Mol. Med., 5, 1196, 10.1002/emmm.201302827
Singh, 2010, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, 29, 4741, 10.1038/onc.2010.215
Sinha, 2007, Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res., 67, 4507, 10.1158/0008-5472.CAN-06-4174
Song, 2006, Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene, Cancer Chemother. Pharmacol., 58, 776, 10.1007/s00280-006-0224-7
Soon, 2013, Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells, Endocr. Relat. Cancer, 20, 1, 10.1530/ERC-12-0227
Sotelo, 2006, Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial, Ann. Intern. Med., 144, 337, 10.7326/0003-4819-144-5-200603070-00008
Steinberg, 2017, Myeloid cells that impair immunotherapy are restored in melanomas with acquired resistance to BRAF inhibitors, Cancer Res., 77, 1599, 10.1158/0008-5472.CAN-16-1755
Steinbichler, 2016, Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells, Oncotarget, 7, 2508, 10.18632/oncotarget.6210
Stolina, 2000, Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis, J. Immunol., 164, 361, 10.4049/jimmunol.164.1.361
Sui, 2013, Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, Cell Death Dis., 4, e838, 10.1038/cddis.2013.350
Sui, 2014, Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies, Oncol Res Treatm, 37, 584, 10.1159/000367802
Sun, 2011, Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development, Autophagy, 7, 1035, 10.4161/auto.7.9.16521
Sun, 2017, HES1 promotes colorectal cancer cell resistance to 5-FU by inducing of EMT and ABC transporter proteins, J. Cancer, 8, 2802, 10.7150/jca.19142
Swystun, 2011, The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models, J. Thromb. Haemost., 9, 767, 10.1111/j.1538-7836.2011.04232.x
Szebeni, 2017, Inflammation and cancer: extra- and intracellular determinants of tumor-associated macrophages as tumor promoters, Mediators Inflamm., 2017, 10.1155/2017/9294018
Takeshita, 1996, Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines, J. Bone Joint Surg. Am., 78, 10.2106/00004623-199603000-00007
Talmadge, 2013, History of myeloid-derived suppressor cells, Nat. Rev. Cancer, 13, 739, 10.1038/nrc3581
Tanriover, 2018, Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells, Clin. Breast Cancer, 18, e1067, 10.1016/j.clbc.2018.03.013
Tcyganov, 2018, Plasticity of myeloid-derived suppressor cells in cancer, Curr. Opin. Immunol., 51, 76, 10.1016/j.coi.2018.03.009
Thews, 2008, Activity of drug efflux transporters in tumor cells under hypoxic conditions, Adv. Exp. Med. Biol., 614, 157, 10.1007/978-0-387-74911-2_19
Thoreau, 2015, Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site, Oncotarget, 6, 27832, 10.18632/oncotarget.4940
Tomono, 2017, Snail-induced epithelial-to-mesenchymal transition enhances P-gp-mediated multidrug resistance in HCC827 Cells, J Pharmaceut Sci, 106, 2642, 10.1016/j.xphs.2017.03.011
Tong, 2018, Cancer stem cells and hypoxia-inducible factors (Review), Int. J. Oncol., 53, 469
Toste, 2016, Chemotherapy-induced inflammatory gene signature and protumorigenic phenotype in pancreatic CAFs via stress-associated MAPK, Mol. Cancer Res., 14, 437, 10.1158/1541-7786.MCR-15-0348
Turovskaya, 2008, RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis, Carcinogenesis, 29, 2035, 10.1093/carcin/bgn188
Umansky, 2012, Melanoma-induced immunosuppression and its neutralization, Semin. Cancer Biol., 22, 319, 10.1016/j.semcancer.2012.02.003
Varga, 2008, Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells, J. Leukoc. Biol., 84, 644, 10.1189/jlb.1107768
Vasconcelos, 2019, Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance, Drug Resist. Updat., 47, 10.1016/j.drup.2019.100647
Vasquez-Dunddel, 2013, STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients, J. Clin. Invest., 123, 1580, 10.1172/JCI60083
Vazquez-Martin, 2010, Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status, Cell Cycle, 9, 3807, 10.4161/cc.9.18.13131
Vega, 2004, Snail blocks the cell cycle and confers resistance to cell death, Genes Dev., 18, 1131, 10.1101/gad.294104
Veglia, 2018, Myeloid-derived suppressor cells coming of age, Nat. Immunol., 19, 108, 10.1038/s41590-017-0022-x
Vellinga, 2015, SIRT1/PGC1alpha-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer, Clin. Cancer Res., 21, 2870, 10.1158/1078-0432.CCR-14-2290
Vendramini-Costa, 2012, Molecular link mechanisms between inflammation and cancer, Curr. Pharm. Des., 18, 3831, 10.2174/138161212802083707
Vlaicu, 2013, Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator, BMC Cancer, 13, 197, 10.1186/1471-2407-13-197
Volm, 2015, Prediction of cancer drug resistance and implications for personalized medicine, Front. Oncol., 5, 282, 10.3389/fonc.2015.00282
Wang, 2013, Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins, J. Immunol., 190, 794, 10.4049/jimmunol.1202088
Wang, 2014, Lung cancer stem cells and implications for future therapeutics, Cell Biochem. Biophys., 69, 389, 10.1007/s12013-014-9844-4
Wang, 2015, Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway, Oncotarget, 6, 36713, 10.18632/oncotarget.5457
Wang, 2017, Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro, Cancer Immunol. Immunother., 66, 355, 10.1007/s00262-016-1935-1
Wang, 2017, Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase, Oncotarget, 8, 87860, 10.18632/oncotarget.21231
Wang, 2018, Suppression of TGF-beta1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins, Artif. Cells Nanomed. Biotechnol., 46, 1505, 10.1080/21691401.2017.1374285
Wartenberg, 2003, Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species, FASEB J., 17, 503, 10.1096/fj.02-0358fje
Wartenberg, 2005, Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids, FEBS Lett., 579, 4541, 10.1016/j.febslet.2005.06.078
Weber, 2005, Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system, Cancer Immunol. Immunother., 54, 898, 10.1007/s00262-004-0652-3
Weber, 2018, Myeloid-derived suppressor cells hinder the anti-cancer activity of immune checkpoint inhibitors, Front. Immunol., 9, 1310, 10.3389/fimmu.2018.01310
Wen, 2019, Eribulin synergistically increases anti-tumor activity of an mTOR inhibitor by inhibiting pAKT/pS6K/pS6 in triple negative breast cancer, Cells, 8, 1010, 10.3390/cells8091010
Weroha, 2011, Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma, Gynecol. Oncol., 122, 116, 10.1016/j.ygyno.2011.03.030
Wheaton, 2014, Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis, Elife, 3, 10.7554/eLife.02242
Wijdeven, 2016, Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics, Drug Resist. Updat., 28, 65, 10.1016/j.drup.2016.07.001
Wilde, 2017, Metabolic coupling and the Reverse Warburg Effect in cancer: implications for novel biomarker and anticancer agent development, Sem Oncol, 44, 198, 10.1053/j.seminoncol.2017.10.004
Wilson, 2020, Emerging mechanisms by which EMT programs control stemness, Trends Cancer, S2405-8033, 30120
Witkiewicz, 2009, An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers, Am. J. Pathol., 174, 2023, 10.2353/ajpath.2009.080873
Wojtowicz, 2015, Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines, Biomed. Pharmacother., 74, 49, 10.1016/j.biopha.2015.07.001
Wozniak, 2015, Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions, Exp. Mol. Pathol., 99, 707, 10.1016/j.yexmp.2015.11.014
Wu, 2013, The role of IL-6 in the radiation response of prostate cancer, Radiat. Oncol., 8, 159, 10.1186/1748-717X-8-159
Xia, 2005, Effects of hypoxia on expression of P-gp and multidrug resistance protein in human lung adenocarcinoma A549 cell line, J. Huazhong Univ. Sci. Technol. Med. Sci., 25, 279, 10.1007/BF02828142
Xie, 2013, Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells, Oncol. Lett., 6, 232, 10.3892/ol.2013.1321
Xin, 2013, Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties, J. Pharmacol. Sci., 122, 299, 10.1254/jphs.13025FP
Xu, 2009, TGF-beta-induced epithelial to mesenchymal transition, Cell Res., 19, 156, 10.1038/cr.2009.5
Xu, 2014, Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner, BMC Cancer, 14, 330, 10.1186/1471-2407-14-330
Xu, 2017, Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer, Exp. Cell Res., 351, 142, 10.1016/j.yexcr.2017.01.008
Yamaguchi, 2020, An emerging model for cancer development from a tumor microenvironment perspective in mice and humans, Adv. Exp. Med. Biol., 1225, 19, 10.1007/978-3-030-35727-6_2
Yamamoto, 2019, Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide, Immunol. Lett., 211, 41, 10.1016/j.imlet.2019.05.012
Yang, 2008, Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis, Dev. Cell, 14, 818, 10.1016/j.devcel.2008.05.009
Yang, 2004, Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis, Cancer Cell, 6, 409, 10.1016/j.ccr.2004.08.031
Yang, 2008, Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis, Cancer Cell, 13, 23, 10.1016/j.ccr.2007.12.004
Yang, 2014, S100A8 contributes to drug resistance by promoting autophagy in leukemia cells, PLoS One, 9
Yang, 2016, The hypoxia-mimetic agent CoCl₂ induces chemotherapy resistance in LOVO colorectal cancer cells, Mol. Med. Rep., 13, 2583, 10.3892/mmr.2016.4836
Yao, 2010, TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer, Proc Natl Acad Sci U S A, 107, 15535, 10.1073/pnas.1009472107
Yao, 2012, Monocyte chemoattractant protein-1 mediates angiotensin II-induced vascular smooth muscle cell proliferation via SAPK/JNK and ERK1/2, Mol. Cell. Biochem., 366, 355, 10.1007/s11010-012-1315-x
Yin, 2017, The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6, Clin. Cancer Res., 23, 7375, 10.1158/1078-0432.CCR-17-1283
Yin, 2019, Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells, Cell Oncol, 42, 459, 10.1007/s13402-019-00446-y
Yook, 2006, A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells, Nat. Cell Biol., 8, 1398, 10.1038/ncb1508
Yoon, 2016, Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-beta, Cell Death Dis., 7, e2191, 10.1038/cddis.2016.90
Yoshiba, 2009, Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest, Oral Oncol., 45, 109, 10.1016/j.oraloncology.2008.04.002
Yoshida, 2016, ZEB1 mediates acquired resistance to the epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer, PLoS One, 11, 10.1371/journal.pone.0147344
Yu, 2014, Revisiting STAT3 signalling in cancer: new and unexpected biological functions, Nat. Rev. Cancer, 14, 736, 10.1038/nrc3818
Zhan, 2015, NOX1 mediates chemoresistance via HIF1α/MDR1 pathway in gallbladder cancer, Biochem. Biophys. Res. Commun., 468, 79, 10.1016/j.bbrc.2015.10.161
Zhang, 2006, Hypoxia-inducible factor-1alpha suppressing apoptosis and increasing tolerance of lung cancer cells to chemotherapy, J. Huazhong Univ. Sci. Technol. Med. Sci., 26, 520, 10.1007/s11596-006-0508-5
Zhang, 2010, Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects, Clin. Cancer Res., 16, 3420, 10.1158/1078-0432.CCR-09-2904
Zhang, 2013, A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells, Cell Res., 23, 394, 10.1038/cr.2012.178
Zhang, 2014, Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells, Cancer Sci., 105, 1109, 10.1111/cas.12483
Zhang, 2014, ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1, Nat. Cell Biol., 16, 864, 10.1038/ncb3013
Zhang, 2017, Knockdown of hypoxia-inducible factor 1α improved the efficacy of low-dose metronomic chemotherapy of paclitaxel in human colon cancer xenografts, Technol. Cancer Res. Treat., 16, 609, 10.1177/1533034616665720
Zhang, 2017, Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway, Mol. Med. Rep., 15, 1869, 10.3892/mmr.2017.6189
Zhang, 2018, Micro-RNA-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer, Oncol. Res., 26, 827, 10.3727/096504017X14934840662335
Zhang, 2018, SOCS3 Suppression promoted the Recruitment of CD11b(+)Gr-1(-)F4/80(-)MHCII(-) Early-stage myeloid-derived suppressor cells and accelerated interleukin-6-related tumor invasion via affecting myeloid differentiation in breast cancer, Front. Immunol., 9, 1699, 10.3389/fimmu.2018.01699
Zhang, 2020, CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling, Lab. Invest., 100, 619, 10.1038/s41374-019-0345-3
Zheng, 2015, Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer, Nature, 527, 525, 10.1038/nature16064
Zhitomirsky, 2016, Lysosomes as mediators of drug resistance in cancer, Drug Resist. Updat., 24, 23, 10.1016/j.drup.2015.11.004
Zhong, 2020, Wnt signaling and drug resistance in cancer, Mol. Pharmacol., 97, 72, 10.1124/mol.119.117978
Zhong, 1994, Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6, Science, 264, 95, 10.1126/science.8140422
Zhong, 2016, A novel IL6 antibody sensitizes multiple tumor types to chemotherapy including trastuzumab-resistant tumors, Cancer Res., 76, 480, 10.1158/0008-5472.CAN-15-0883
Zhou, 2004, Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition, Nat. Cell Biol., 6, 931, 10.1038/ncb1173
Zhou, 2010, Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol, Mol. Cancer, 9, 33, 10.1186/1476-4598-9-33
Zhou, 2012, Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells, Cancer Res., 72, 304, 10.1158/0008-5472.CAN-11-1674
Zhou, 2015, FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition, Cancer Lett., 363, 137, 10.1016/j.canlet.2015.04.008
Zhou, 2017, Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells, J. Cancer Res. Clin. Oncol., 143, 1371, 10.1007/s00432-017-2394-6
Zhou, 2018, miR-200c inhibits TGF-beta-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer, Cancer Gene Ther., 25, 68, 10.1038/s41417-017-0005-y
Zhou, 2019, Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment, J. Cancer Res. Clin. Oncol., 145, 329, 10.1007/s00432-018-2790-6
Zhu, 2012, Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells, Oncol. Rep., 27, 1027, 10.3892/or.2012.1633
Zins, 2020, Cancer immunotherapy: targeting tumor-associated macrophages by gene silencing, Methods Mol. Biol., 2115, 289, 10.1007/978-1-0716-0290-4_17